drugset / Trial / NCT02850003

Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

NCT02850003

Phase 1 Completed 20 enrolled Bausch Health Americas, Inc.
NaSingle-groupOpen-labelTreatment

Summary

Study designed to assess the safety and plasma PK of tretinoin and its metabolites from topically applied IDP-120 gel.

Timeline

Start
2016-06
Primary completion
2016-10
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tretinoin Small molecule Topical

Indications